| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DENND2A TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I DENND11 TBC1D3G PLEKHG5 TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.41e-10 | 507 | 58 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DENND2A TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I DENND11 TBC1D3G PLEKHG5 TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.41e-10 | 507 | 58 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 4.14e-10 | 279 | 58 | 11 | GO:0005096 |
| GeneOntologyMolecularFunction | enzyme regulator activity | CASP8AP2 DENND2A NCOR1 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D EGFR TBC1D3I DENND11 TBC1D3G PLEKHG5 TBC1D3C TBC1D3B RCAN3 RCAN2 TBC1D3K TBC1D3F | 8.68e-09 | 1418 | 58 | 19 | GO:0030234 |
| GeneOntologyMolecularFunction | enzyme activator activity | CASP8AP2 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D EGFR TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.73e-08 | 656 | 58 | 13 | GO:0008047 |
| GeneOntologyMolecularFunction | molecular function activator activity | CASP8AP2 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D EGFR SEMA3B TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 8.50e-06 | 1233 | 58 | 14 | GO:0140677 |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine phosphatase regulator activity | 8.25e-05 | 5 | 58 | 2 | GO:0008597 | |
| GeneOntologyMolecularFunction | sodium channel activity | 4.65e-04 | 52 | 58 | 3 | GO:0005272 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 8.06e-15 | 109 | 57 | 11 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.79e-11 | 244 | 57 | 11 | GO:0043547 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | CASP8AP2 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D FGFR2 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 7.72e-10 | 499 | 57 | 13 | GO:0051345 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.67e-09 | 335 | 57 | 11 | GO:0043087 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | CASP8AP2 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D EGFR FGFR2 TBC1D3I TOPORS TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 8.08e-08 | 1028 | 57 | 15 | GO:0043085 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | CASP8AP2 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D FGFR2 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.93e-07 | 878 | 57 | 13 | GO:0051336 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | ABRA CASP8AP2 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D EGFR FGFR2 TBC1D3I TOPORS TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.00e-06 | 1430 | 57 | 16 | GO:0044093 |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 8.19e-05 | 83 | 57 | 4 | GO:1902893 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 8.58e-05 | 84 | 57 | 4 | GO:0061614 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 1.89e-04 | 103 | 57 | 4 | GO:2000628 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 3.29e-04 | 119 | 57 | 4 | GO:0010586 | |
| HumanPheno | Abnormality of the incisor | 1.42e-05 | 108 | 16 | 5 | HP:0000676 | |
| HumanPheno | Abnormal incisor morphology | 3.25e-05 | 62 | 16 | 4 | HP:0011063 | |
| HumanPheno | Recurrent mycobacterial infections | 3.25e-05 | 62 | 16 | 4 | HP:0011274 | |
| HumanPheno | Macrodontia | 1.08e-04 | 31 | 16 | 3 | HP:0001572 | |
| MousePheno | abnormal heart ventricle size | 2.68e-05 | 228 | 37 | 6 | MP:0031543 | |
| Domain | TBC | USP6 TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.05e-18 | 49 | 57 | 11 | SM00164 |
| Domain | RabGAP-TBC | USP6 TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.31e-18 | 53 | 57 | 11 | PF00566 |
| Domain | TBC_RABGAP | USP6 TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 8.29e-18 | 55 | 57 | 11 | PS50086 |
| Domain | Rab-GTPase-TBC_dom | USP6 TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 8.29e-18 | 55 | 57 | 11 | IPR000195 |
| Domain | N-CoR_GPS2_interact | 9.15e-06 | 2 | 57 | 2 | IPR031557 | |
| Domain | GPS2_interact | 9.15e-06 | 2 | 57 | 2 | PF15784 | |
| Domain | Calcipressin | 2.74e-05 | 3 | 57 | 2 | PF04847 | |
| Domain | Calcipressin | 2.74e-05 | 3 | 57 | 2 | IPR006931 | |
| Domain | Myb_DNA-binding | 1.65e-04 | 35 | 57 | 3 | PF00249 | |
| Domain | MYB_LIKE | 2.11e-04 | 38 | 57 | 3 | PS50090 | |
| Domain | SANT | 4.77e-04 | 50 | 57 | 3 | SM00717 | |
| Domain | SANT/Myb | 5.36e-04 | 52 | 57 | 3 | IPR001005 | |
| Domain | DUF1605 | 1.21e-03 | 17 | 57 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 1.21e-03 | 17 | 57 | 2 | PF07717 | |
| Domain | HA2 | 1.36e-03 | 18 | 57 | 2 | SM00847 | |
| Domain | HA2 | 1.36e-03 | 18 | 57 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 1.36e-03 | 18 | 57 | 2 | IPR007502 | |
| Domain | TyrKc | 2.46e-03 | 88 | 57 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 2.46e-03 | 88 | 57 | 3 | IPR020635 | |
| Domain | SANT_dom | 2.84e-03 | 26 | 57 | 2 | IPR017884 | |
| Domain | PROTEIN_KINASE_TYR | 3.24e-03 | 97 | 57 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 3.24e-03 | 97 | 57 | 3 | IPR008266 | |
| Domain | SANT | 3.29e-03 | 28 | 57 | 2 | PS51293 | |
| Domain | PTPc | 5.39e-03 | 36 | 57 | 2 | SM00194 | |
| Domain | DEAH_ATP_HELICASE | 6.00e-03 | 38 | 57 | 2 | PS00690 | |
| Domain | TYR_PHOSPHATASE_PTP | 6.31e-03 | 39 | 57 | 2 | PS50055 | |
| Domain | PTPase_domain | 6.95e-03 | 41 | 57 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 6.95e-03 | 41 | 57 | 2 | PF00102 | |
| Domain | Pkinase_Tyr | 7.18e-03 | 129 | 57 | 3 | PF07714 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K | 1.06e-11 | 99 | 42 | 9 | M46448 |
| Pathway | REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX | 1.80e-04 | 7 | 42 | 2 | M27899 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 2.99e-04 | 44 | 42 | 3 | M27295 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 3.08e-04 | 9 | 42 | 2 | M29809 | |
| Pathway | PID_HES_HEY_PATHWAY | 3.87e-04 | 48 | 42 | 3 | M288 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 4.69e-04 | 11 | 42 | 2 | MM1432 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 4.69e-04 | 11 | 42 | 2 | M18837 | |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.01e-31 | 11 | 58 | 11 | 16863688 |
| Pubmed | 6.96e-12 | 4 | 58 | 4 | 8406013 | ||
| Pubmed | 3.48e-11 | 5 | 58 | 4 | 12604796 | ||
| Pubmed | 3.48e-11 | 5 | 58 | 4 | 8471161 | ||
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 4.07e-11 | 74 | 58 | 7 | 16625196 | |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 1.76e-08 | 4 | 58 | 3 | 12359748 | |
| Pubmed | PTPD1 supports receptor stability and mitogenic signaling in bladder cancer cells. | 2.73e-06 | 2 | 58 | 2 | 20923765 | |
| Pubmed | CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas. | 2.73e-06 | 2 | 58 | 2 | 27733359 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 26386721 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 22944139 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 21131350 | ||
| Pubmed | Promoter region of the murine fibroblast growth factor receptor 2 (bek/KGFR) gene. | 2.73e-06 | 2 | 58 | 2 | 1408137 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 19299558 | ||
| Pubmed | Unique forms of human and mouse nuclear receptor corepressor SMRT. | 2.73e-06 | 2 | 58 | 2 | 10077563 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 39106294 | ||
| Pubmed | Evolution of NCoR-1 and NCoR-2 corepressor alternative mRNA splicing in placental mammals. | 2.73e-06 | 2 | 58 | 2 | 31208445 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 29531310 | ||
| Pubmed | The endosomal transcriptional regulator RNF11 integrates degradation and transport of EGFR. | 2.73e-06 | 2 | 58 | 2 | 27872256 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 24550739 | ||
| Pubmed | Regulation of corepressor alternative mRNA splicing by hormonal and metabolic signaling. | 2.73e-06 | 2 | 58 | 2 | 26166430 | |
| Pubmed | Functional interactions with Pit-1 reorganize co-repressor complexes in the living cell nucleus. | 8.19e-06 | 3 | 58 | 2 | 16030140 | |
| Pubmed | Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor. | 8.19e-06 | 3 | 58 | 2 | 19098224 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16373395 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 31404087 | ||
| Pubmed | Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo. | 8.19e-06 | 3 | 58 | 2 | 23292142 | |
| Pubmed | Diversity of human copy number variation and multicopy genes. | 8.19e-06 | 3 | 58 | 2 | 21030649 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 24268577 | ||
| Pubmed | Oligomerization of ETO is obligatory for corepressor interaction. | 8.19e-06 | 3 | 58 | 2 | 11113190 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 31042082 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 25062045 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 21518914 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16299810 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 15802375 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 36238311 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 11080588 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18319245 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18852122 | ||
| Pubmed | Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy. | 8.19e-06 | 3 | 58 | 2 | 21173787 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22337871 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 15016838 | ||
| Pubmed | PIAS1 interacts with FLASH and enhances its co-activation of c-Myb. | 8.19e-06 | 3 | 58 | 2 | 21338522 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18408764 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 10756093 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 34390859 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 12011091 | ||
| Pubmed | Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin. | 8.19e-06 | 3 | 58 | 2 | 17595344 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 9890755 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 10406466 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 36316474 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18052923 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 11997503 | ||
| Pubmed | 9.86e-06 | 25 | 58 | 3 | 11294897 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 18632669 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 19147680 | ||
| Pubmed | NCoR1 and SMRT play unique roles in thyroid hormone action in vivo. | 1.64e-05 | 4 | 58 | 2 | 25421714 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 15878880 | ||
| Pubmed | FBI-1 functions as a novel AR co-repressor in prostate cancer cells. | 1.64e-05 | 4 | 58 | 2 | 20812024 | |
| Pubmed | The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. | 1.64e-05 | 4 | 58 | 2 | 11509652 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 19211732 | ||
| Pubmed | A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor. | 1.64e-05 | 4 | 58 | 2 | 20543827 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 26712002 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 26712006 | ||
| Pubmed | MicroRNAs are mediators of androgen action in prostate and muscle. | 1.64e-05 | 4 | 58 | 2 | 21048966 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 9819405 | ||
| Pubmed | Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers. | 1.64e-05 | 4 | 58 | 2 | 18362166 | |
| Pubmed | Dichotomous engagement of HDAC3 activity governs inflammatory responses. | 1.64e-05 | 4 | 58 | 2 | 32760002 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 32072640 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 17918184 | ||
| Pubmed | Direct association between the CREB-binding protein (CBP) and nuclear receptor corepressor (N-CoR). | 1.64e-05 | 4 | 58 | 2 | 17073437 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 16024608 | ||
| Pubmed | Transcriptional integration of TLR2 and TLR4 signaling at the NCoR derepression checkpoint. | 1.64e-05 | 4 | 58 | 2 | 19595715 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 18724389 | ||
| Pubmed | Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1. | 1.64e-05 | 4 | 58 | 2 | 16121196 | |
| Pubmed | EGF-responsive neural stem cells are a transient population in the developing mouse spinal cord. | 1.64e-05 | 4 | 58 | 2 | 11553295 | |
| Pubmed | A SANT motif in the SMRT corepressor interprets the histone code and promotes histone deacetylation. | 1.64e-05 | 4 | 58 | 2 | 12840002 | |
| Pubmed | Nuclear receptor coregulator SNP discovery and impact on breast cancer risk. | 1.64e-05 | 4 | 58 | 2 | 20003447 | |
| Pubmed | 1.73e-05 | 30 | 58 | 3 | 16524929 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 9038232 | ||
| Pubmed | ERbeta Binds N-CoR in the Presence of Estrogens via an LXXLL-like Motif in the N-CoR C-terminus. | 2.72e-05 | 5 | 58 | 2 | 12904255 | |
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 26853422 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 25783055 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 21088000 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 23703729 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 15531890 | ||
| Pubmed | Combinatorial roles of the nuclear receptor corepressor in transcription and development. | 2.72e-05 | 5 | 58 | 2 | 11030619 | |
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 16033423 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 22445366 | ||
| Pubmed | Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells. | 2.72e-05 | 5 | 58 | 2 | 15729358 | |
| Pubmed | Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas. | 2.72e-05 | 5 | 58 | 2 | 21143702 | |
| Pubmed | The histone deacetylase-3 complex contains nuclear receptor corepressors. | 2.72e-05 | 5 | 58 | 2 | 10860984 | |
| Pubmed | A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. | 2.72e-05 | 5 | 58 | 2 | 10809664 | |
| Pubmed | Mouse germline restriction of Oct4 expression by germ cell nuclear factor. | 2.72e-05 | 5 | 58 | 2 | 11702949 | |
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 7566114 | ||
| Pubmed | Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. | 2.72e-05 | 5 | 58 | 2 | 15175761 | |
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 14593076 | ||
| Pubmed | Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. | 2.72e-05 | 5 | 58 | 2 | 11865059 | |
| Pubmed | Nectin-1 binds and signals through the fibroblast growth factor receptor. | 2.72e-05 | 5 | 58 | 2 | 22955284 | |
| Pubmed | Genome-Nuclear Lamina Interactions Regulate Cardiac Stem Cell Lineage Restriction. | 2.72e-05 | 5 | 58 | 2 | 29033129 | |
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 12612085 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 16712523 | ||
| Interaction | TBC1D3L interactions | 7.58e-06 | 2 | 56 | 2 | int:TBC1D3L | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.77e-17 | 149 | 58 | 11 | chr17q12 |
| Cytoband | 17q12 | 1.76e-07 | 99 | 58 | 5 | 17q12 | |
| Cytoband | 8q22.2 | 3.90e-04 | 23 | 58 | 2 | 8q22.2 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.22e-04 | 53 | 33 | 3 | 532 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.02e-03 | 26 | 33 | 2 | 253 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 3.75e-03 | 50 | 33 | 2 | 1293 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.63e-12 | 90 | 58 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TYK2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TRPM2 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.35e-10 | 281 | 58 | 11 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TYK2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TRPM2 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.35e-10 | 281 | 58 | 11 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G PLEKHG5 TBC1D3C TBC1D3B TBC1D3K TBC1D3F BAHCC1 | 9.30e-10 | 320 | 58 | 11 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 6.04e-09 | 213 | 58 | 9 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 6.04e-09 | 213 | 58 | 9 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.83e-08 | 242 | 58 | 9 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | DENND2A TBC1D3 TBC1D3H TBC1D3L TBC1D3D TRPM2 PTPN21 TBC1D3G PLEKHG5 TBC1D3C TBC1D3B RCAN3 RCAN2 TBC1D3K TBC1D3F BAHCC1 | 4.74e-08 | 1153 | 58 | 16 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | DENND2A DMXL2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D NECTIN1 SEMA3B FGFR2 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F BAHCC1 | 1.28e-07 | 1075 | 58 | 15 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | TYK2 AFMID TBC1D3 TBC1D3H TBC1D3L TBC1D3D EGFR SEMA3B TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.84e-06 | 1049 | 58 | 13 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | DENND2A DMXL2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D SEMA3B FGFR2 PTPN21 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F BAHCC1 | 6.32e-06 | 1466 | 58 | 15 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.59e-06 | 167 | 58 | 5 | 49d9220f22d10ff06c0512c9c40c26ad51728e4f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.59e-06 | 167 | 58 | 5 | 7ec032a98a13504d15c7e3a4e259278d07f40180 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.59e-06 | 167 | 58 | 5 | 5e3588eee73693a996bb4846427cf0038ceafbca | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.00e-06 | 172 | 58 | 5 | 04fabb40fa9357d8902f3b04adc15231626cd9f8 | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.00e-06 | 172 | 58 | 5 | dd3a23dc78dc6939f41126f8d7bd23a2e4713647 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-06 | 184 | 58 | 5 | a60802e11dcc5f932811260b08a95a32f60f6b19 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-06 | 184 | 58 | 5 | 39c230d32e4259bc784e0edfd9e2884c96898564 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-06 | 184 | 58 | 5 | 2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.23e-05 | 157 | 58 | 4 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.49e-05 | 159 | 58 | 4 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.80e-05 | 168 | 58 | 4 | 38ba7737ae0afffcbd3aa499403e83c24a922127 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.80e-05 | 168 | 58 | 4 | 0f736d58cb0ff042fa3ce58e36bde37b6976f8fc | |
| ToppCell | Ciliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 7.12e-05 | 170 | 58 | 4 | 8b7ef1464ea589886b575ebad5447b085cbdcdba | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 7.28e-05 | 171 | 58 | 4 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.79e-05 | 174 | 58 | 4 | b7f5492ce8098f7eb0aef30ee558d00738d59d0e | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.79e-05 | 174 | 58 | 4 | 71730503be3d9c839c4c9e950145e2101d682a1c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.79e-05 | 174 | 58 | 4 | ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.79e-05 | 174 | 58 | 4 | cafe4d6b5f08d8888e9db6e196c66df991c03e7b | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 176 | 58 | 4 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.32e-05 | 177 | 58 | 4 | a235ff4f37a7622216526191efc4832fb8ed6957 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.32e-05 | 177 | 58 | 4 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.32e-05 | 177 | 58 | 4 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.32e-05 | 177 | 58 | 4 | 43dce527392f3b8364bb6a55268ce9d6518d3a29 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.51e-05 | 178 | 58 | 4 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 178 | 58 | 4 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 8.69e-05 | 179 | 58 | 4 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.88e-05 | 180 | 58 | 4 | 5286e66ff6b7154390b3e9c189704a71d56bc89c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.88e-05 | 180 | 58 | 4 | d553aba594f5304f1c09ff9c6d49b64cd7ee7850 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.88e-05 | 180 | 58 | 4 | 2b6b295b5c21b829828afae9ab4c3eb9233f6f45 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.88e-05 | 180 | 58 | 4 | bf587387145a2b5e83766fbccf76eecc6d5e8241 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.07e-05 | 181 | 58 | 4 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.07e-05 | 181 | 58 | 4 | 2b53a65ca5616a7b9f64232c3e0b7212d1e2f063 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.07e-05 | 181 | 58 | 4 | 6aef84616e8d2faf54b7e9e6cd02f33c3066dabc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.07e-05 | 181 | 58 | 4 | 40d3829ae4aaf81e8616c3499ff8933137fc1cc4 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pre-B|bone_marrow / Manually curated celltypes from each tissue | 9.27e-05 | 182 | 58 | 4 | a5fd392178c2f533e265d2e3ce63b90c2553e4c1 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Ionocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.27e-05 | 182 | 58 | 4 | 6e7dac78dc030f74e546b9f6db07556e9bb13ac2 | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 9.27e-05 | 182 | 58 | 4 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.27e-05 | 182 | 58 | 4 | 3fddadb2ff75013ec6eeb415872667a6bae1da2d | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.27e-05 | 182 | 58 | 4 | cd972d30519db706477c6b0c901165b81b74abed | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 9.47e-05 | 183 | 58 | 4 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 9.87e-05 | 185 | 58 | 4 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 1.01e-04 | 186 | 58 | 4 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 58 | 4 | fddc6b93f98b10aaf8d4ebc142b46d8213f3129d | |
| ToppCell | Control-Epithelial-ATI|Control / Disease state, Lineage and Cell class | 1.03e-04 | 187 | 58 | 4 | fdd1c57b61ca9392ac27661a82729f37593df63c | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.03e-04 | 187 | 58 | 4 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 1.03e-04 | 187 | 58 | 4 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 189 | 58 | 4 | a618a1ddf5097a010c6c2c7341f3a0bd46a29c02 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 189 | 58 | 4 | 4e61f9cd1c06bddb47ebf98affc0f97770e26e8c | |
| ToppCell | ASK440-Epithelial-Secretory|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.16e-04 | 193 | 58 | 4 | 50e98d91697c7af6a3de39e52edde6dd2b67b512 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.19e-04 | 194 | 58 | 4 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-04 | 196 | 58 | 4 | ef650ff106a76c1e926e13c7f002fbc452cc48ae | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Mucous-Mucous|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-04 | 196 | 58 | 4 | 357a5440aeebf69688bfe9fbc8585950ad00906b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-04 | 196 | 58 | 4 | 72b6a68ee760599ea86cd2d712bfd17b7b4ee417 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Mucous|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-04 | 196 | 58 | 4 | 98e3f9c886063def16c74ab75fc81511a7872f1c | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.28e-04 | 198 | 58 | 4 | f632342e1e8911dd82b5df171776a84c7dc3f931 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-04 | 199 | 58 | 4 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-04 | 199 | 58 | 4 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 199 | 58 | 4 | 4099df3c052a9536d72ba01492317be7d83a79ad | |
| ToppCell | distal-Epithelial-Mucous-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.31e-04 | 199 | 58 | 4 | 35fb7bd35e53d8ca189fe8c7744211a5201081f6 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-04 | 199 | 58 | 4 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-04 | 199 | 58 | 4 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | distal-2-Epithelial-Basal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.33e-04 | 200 | 58 | 4 | 9beb128841c50241aa819261f21bf66f881ea125 | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 4.37e-06 | 192 | 51 | 6 | 3400_DN | |
| Disease | Endometrial adenocarcinoma | 1.68e-05 | 4 | 50 | 2 | C1153706 | |
| Disease | myelofibrosis (implicated_via_orthology) | 4.20e-05 | 6 | 50 | 2 | DOID:4971 (implicated_via_orthology) | |
| Disease | macrophage inflammatory protein 1b measurement | 8.43e-05 | 136 | 50 | 4 | EFO_0008219 | |
| Disease | estrogen-receptor positive breast cancer | 1.01e-04 | 9 | 50 | 2 | EFO_1000649 | |
| Disease | Head and Neck Carcinoma | 1.26e-04 | 10 | 50 | 2 | C3887461 | |
| Disease | Gastric cancer | 1.53e-04 | 11 | 50 | 2 | cv:C0024623 | |
| Disease | Neoplasm of stomach | 1.53e-04 | 11 | 50 | 2 | cv:C0038356 | |
| Disease | GASTRIC CANCER | 1.53e-04 | 11 | 50 | 2 | 613659 | |
| Disease | Nonorganic psychosis | 2.22e-04 | 69 | 50 | 3 | C0349204 | |
| Disease | Endometrial Carcinoma | 2.51e-04 | 72 | 50 | 3 | C0476089 | |
| Disease | Lung cancer | 2.53e-04 | 14 | 50 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 2.53e-04 | 14 | 50 | 2 | 211980 | |
| Disease | Neoplasm of lung | 2.53e-04 | 14 | 50 | 2 | cv:C0024121 | |
| Disease | Down syndrome (implicated_via_orthology) | 2.91e-04 | 15 | 50 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Benign neoplasm of stomach | 3.77e-04 | 17 | 50 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.77e-04 | 17 | 50 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 3.77e-04 | 17 | 50 | 2 | C0154060 | |
| Disease | thyroxine measurement | 3.82e-04 | 83 | 50 | 3 | EFO_0005130 | |
| Disease | Malignant neoplasm of endometrium | 4.23e-04 | 18 | 50 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 4.23e-04 | 18 | 50 | 2 | C0346191 | |
| Disease | CCL4 measurement | 5.24e-04 | 20 | 50 | 2 | EFO_0004751 | |
| Disease | fetal hemoglobin measurement | 5.79e-04 | 21 | 50 | 2 | EFO_0004576 | |
| Disease | Stomach Carcinoma | 5.79e-04 | 21 | 50 | 2 | C0699791 | |
| Disease | Tinnitus, wellbeing measurement | 5.85e-04 | 96 | 50 | 3 | EFO_0007869, HP_0000360 | |
| Disease | portal hypertension (biomarker_via_orthology) | 6.36e-04 | 22 | 50 | 2 | DOID:10762 (biomarker_via_orthology) | |
| Disease | Psychotic Disorders | 6.79e-04 | 101 | 50 | 3 | C0033975 | |
| Disease | Carcinoma of lung | 6.96e-04 | 23 | 50 | 2 | C0684249 | |
| Disease | Intrahepatic Cholangiocarcinoma | 7.58e-04 | 24 | 50 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 7.58e-04 | 24 | 50 | 2 | C3805278 | |
| Disease | Cholangiocarcinoma | 8.91e-04 | 26 | 50 | 2 | C0206698 | |
| Disease | platelet crit | 1.06e-03 | 952 | 50 | 7 | EFO_0007985 | |
| Disease | Squamous cell carcinoma of lung | 1.35e-03 | 32 | 50 | 2 | C0149782 | |
| Disease | Head and Neck Neoplasms | 1.44e-03 | 33 | 50 | 2 | C0018671 | |
| Disease | prostate cancer (implicated_via_orthology) | 1.44e-03 | 33 | 50 | 2 | DOID:10283 (implicated_via_orthology) | |
| Disease | verbal-numerical reasoning measurement | 1.44e-03 | 131 | 50 | 3 | EFO_0008394 | |
| Disease | lung disease (biomarker_via_orthology) | 1.62e-03 | 35 | 50 | 2 | DOID:850 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YAHLKAEGKGERRPG | 441 | Q9P281 | |
| HPGYLVEKGEKGDQG | 966 | Q07092 | |
| TKKTKEDYGHPPREG | 4411 | Q96DT5 | |
| LGYPGGKAKVIHKES | 2646 | Q8TDJ6 | |
| EDYPSGKKRAGTDGK | 11 | O43143 | |
| GHPEKYGKGEPKTES | 286 | Q9UKL3 | |
| KLGPGEKYELHAGTE | 141 | Q14206 | |
| SKLGPGEKYELHAGT | 176 | Q9UKA8 | |
| EYSHPQLGGGKGKKK | 746 | O14917 | |
| HTGRYKAGEKEPDPK | 61 | P10914 | |
| KSLLHVPYGDGEGEK | 61 | Q63HM1 | |
| IKHVEKNGSKYGPDG | 291 | P21802 | |
| DSLPKGHVIYEGKKG | 1261 | Q9Y618 | |
| GYEKEGLGDRGEKPA | 311 | Q16849 | |
| KEKYEKLAGRGGPGS | 311 | Q8NHW3 | |
| PEHYPGLGKKEEGEE | 1751 | Q6ZU64 | |
| SKYGLKHLAEEKPDG | 171 | Q8IUF1 | |
| KKVPRDEDDPGKGNY | 161 | Q6ZQN5 | |
| GDYKGEEKDRAPGEK | 251 | Q6H9L7 | |
| YDGLLPKSGKRHLGK | 26 | P10242 | |
| GPEEAEGLRYGHKKS | 686 | Q16825 | |
| LLGAEEKEYHAEGGK | 861 | P00533 | |
| GEPGPKRDEEKKNHY | 186 | Q8WXS5 | |
| RTFKHAGEGDKDGKP | 271 | Q9ULE3 | |
| FYEDKKGVLHAGPGR | 191 | A4D1U4 | |
| AKEPRHYHGKTKGQG | 481 | Q9P0X4 | |
| YDREMKDYGPAKGGK | 71 | O15347 | |
| GIDTDKHKYPIGSGR | 461 | Q9BZB8 | |
| GGKCPKEEDHRAKGL | 786 | Q16099 | |
| LKGPDSHYGTKGLRK | 471 | Q9BX70 | |
| PKGVYDPGRDGSEKK | 81 | Q9Y3C5 | |
| HKKYRKDEGDLPGCL | 131 | Q5H9M0 | |
| ADAKKDPAFGGKHEA | 141 | O75376 | |
| KYEKGHRAGLPEDKG | 21 | B9A6J9 | |
| STRLHKGDEGYGRPK | 276 | Q8N0Z2 | |
| KGDEGYGRPKEGTKT | 281 | Q8N0Z2 | |
| KYEKGHRAGLPEDKG | 21 | A6NDS4 | |
| KYEKGHRAGLPEDKG | 21 | P0C7X1 | |
| HYLRVKAPAKPGDEG | 141 | O94827 | |
| KYEKGHRAGLPEDKG | 21 | A6NER0 | |
| IEDGKGKSPYDPRHR | 161 | Q13214 | |
| GGRKKTEEPGDSYHV | 1226 | O94759 | |
| RKHEDGGGDKKPAEP | 356 | Q07617 | |
| KKPGVSGHGVYELKD | 811 | Q8IWV7 | |
| KYEKGHRAGLPEDKG | 21 | A0A087X179 | |
| KYKDRGILHPKRGTE | 1231 | Q9H6S0 | |
| KPGGKRKYKTRHLEG | 791 | Q9NS56 | |
| YRGKLSKPKIHGDGV | 2101 | Q7Z7G8 | |
| KYEKGHRAGLPEDKG | 21 | A0A087WVF3 | |
| PEYHKFLIGKGGGKI | 736 | Q00341 | |
| AKGLLDKVKDGGYRP | 501 | O96006 | |
| GKKPKETYGGSDLRE | 271 | Q96IQ7 | |
| KYEKGHRAGLPEDKG | 21 | Q6DHY5 | |
| KYEKGHRAGLPEDKG | 21 | Q8IZP1 | |
| KYEKGHRAGLPEDKG | 21 | A0A087X1G2 | |
| KYDKGHRAGLPEDKG | 21 | P35125 | |
| KYEKGHRAGLPEDKG | 21 | A0A087WXS9 | |
| KYEKGHRAGLPEDKG | 21 | Q6IPX1 | |
| YLKKIRDLGEGHFGK | 896 | P29597 | |
| RKVGGPHPKYDEDAK | 451 | Q15223 |